Advertisement

June 9, 2020

MIVI Neuroscience Receives IDE Approval to Study the Q Aspiration Catheter

June 9, 2020—MIVI Neuroscience announced that the FDA has approved an investigational device exemption for the initiation of a human clinical study of the MIVI Q aspiration catheter in the United States. EVaQ is a prospective, multicenter, single-arm study of the Q revascularization system for neurointervention in acute ischemic stroke.

According to the company, the study will assess the Q catheter’s ability to remove thrombus that causes large vessel occlusions in the arteries of the brain. Patient enrollment is planned at up to 12 clinical centers in the United States and additional sites in the European Union.

Principal investigators for the EvaQ study are Lucas Elijovich, MD, with the Semmes Murphy Clinic in Memphis, Tennessee; Brian Jankowitz, MD, with Cooper University Health Care in Camden, New Jersey; and Professor Christophe Cognard, MD, with Purpan University Hospital in Toulouse, France.

Advertisement


June 10, 2020

Studies Published on Clinical Use of Saranas Early Bird Bleed Monitoring System

June 9, 2020

Guerbet's Lipiodol Ultra-Fluid Approved in China for cTACE